Trial · NCT04571619
Outcomes26
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 26
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Pain Interference | The primary outcome of pain interference will be ascertained at Week 12 coinciding with the end of the PCST weekly coaching sessions. | Participants withdrew at various points during the trial. Some participants were not able to complete the PRO assessments. | score on a scale | MEAN |
| SECONDARY | Pain Intensity | Weeks 12, 24, and 36 | Participants withdrew at various points during the study. Some participants were not able to complete the PRO assessments. | score on a scale | MEAN |
| SECONDARY | Pain Catastrophizing | Weeks 12, 24, and 36 | Participants withdrew at various points throughout the study, and some participants were unable to complete the PRO assessments. | score on a scale | MEAN |
| SECONDARY | Opioid Use | Weeks 12, 24, and 36 | Not all participants reported opioid use, as this was not an inclusion criterion but rather a subset of the study population. This outcome was assessed only for those participants reporting opioid use at the time of enrollment. | morphine milliequivalents | MEAN |
| SECONDARY | Number of Falls | Throughout the 36-week follow-up | number of falls | NUMBER | |
| SECONDARY | Rate of Falls | Though Week 36 follow-up | falls/patient year | NUMBER | |
| SECONDARY | Number of Hospitalizations | Through 36-week follow-up | hospitalizations | NUMBER | |
| SECONDARY | Rate of Hospitalizations | Through Week 36 follow-up | hospitalizations/patient year | NUMBER | |
| SECONDARY | Number of Deaths | Through the 36-week follow-up | deaths | NUMBER | |
| SECONDARY | Rate of Deaths | Through Week 36 follow-up | deaths/patient year | NUMBER | |
| SECONDARY | Buprenorphine Acceptability | Through Week 36 | proportion of participants | NUMBER | |
| SECONDARY | Buprenorphine Tolerability | Through Week 36 | proportion of participants | NUMBER | |
| SECONDARY | Overall Sense of Quality of Life | Weeks 12, 24, and 36 | Participants withdrew at various points throughout the study, and some participants were unable to complete the PRO assessments. | score on a scale | MEAN |
| SECONDARY | Physical Functioning | Weeks 12, 24, and 36 | Participants withdrew at various points during the study, and some participants were unable to complete the PRO assessments. | T-score | MEAN |
| SECONDARY | Depression | Weeks 12, 24, and 36 | Participants withdrew at various points during the study, and some participants were unable to complete the PRO assessments. | score on a scale | MEAN |
| SECONDARY | Anxiety | Weeks 12, 24, and 36 | Participants withdrew at various points throughout the trial, and some participants were unable to complete the PRO assessments. | score on a scale | MEAN |
| SECONDARY | Coping | Weeks 12, 24, and 36 | Participants withdrew at various points throughout the trial, and some participants were unable to complete the PRO assessments. | score on a scale | MEAN |
| SECONDARY | Sleep Quality | Weeks 12, 24, and 36 | Participants withdrew at various times during the study, and some participants were unable to complete the PRO assessments. | t-score | MEAN |
| SECONDARY | Fatigue | Weeks 12, 24, and 36 | Participants withdrew at various times during the study, and some participants were unable to complete the PRO assessments. | t-score | MEAN |
| SECONDARY | Satisfaction With Treatment | Weeks 12, 24, and 36 | Participants withdrew at various times throughout the trial, and some participants were unable to complete the PRO assessments. | score on a scale | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04571619/outcomes